Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection

Research Suggests Mild COVID-19 Illness Leaves Behind Lasting Antibody Protection
A paramedic, right, holds a test tube to be used for a blood sample during an antibody testing program operated by the West Midlands Ambulance Service NHS Foundation Trust, in Birmingham, England, on June 5, 2020. Simon Dawson/Getty Images
Meiling Lee
Updated:
0:00

People who had mild COVID-19 have long-lasting antibody protection, according to a study by researchers from Washington University School of Medicine in St. Louis.

Scientists found that individuals who have recovered from a mild case of COVID-19 have long-lived plasma cells in their bone marrow that secretes low levels of antibodies against the CCP (Chinese Communist Party) virus for possibly a lifetime.